Compare ABSI & GDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ABSI | GDRX |
|---|---|---|
| Founded | 2011 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 997.8M | 1.0B |
| IPO Year | 2021 | 2020 |
| Metric | ABSI | GDRX |
|---|---|---|
| Price | $7.14 | $3.11 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 9 |
| Target Price | ★ $6.96 | $3.66 |
| AVG Volume (30 Days) | ★ 4.0M | 942.7K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 10.64 | ★ 125.00 |
| EPS | N/A | ★ N/A |
| Revenue | $4,534,000.00 | ★ $796,853,000.00 |
| Revenue This Year | $215.96 | N/A |
| Revenue Next Year | $319.10 | $5.38 |
| P/E Ratio | ★ N/A | $28.94 |
| Revenue Growth | N/A | ★ 0.57 |
| 52 Week Low | $2.24 | $1.77 |
| 52 Week High | $12.06 | $5.61 |
| Indicator | ABSI | GDRX |
|---|---|---|
| Relative Strength Index (RSI) | 34.84 | 60.21 |
| Support Level | $2.56 | $2.47 |
| Resistance Level | $12.06 | $3.16 |
| Average True Range (ATR) | 0.71 | 0.12 |
| MACD | -0.44 | -0.01 |
| Stochastic Oscillator | 5.44 | 75.64 |
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.
GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.